23 May 2013
Keywords: merck, kgaa, promotes, kl, kley, michael, roemer
Article | 26 February 2007
German drugmaker Merck KGaA says that its has appointed Karl-Ludwig Kley as chairman of its executive board. Dr Kley succeeds ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
26 February 2007
22 May 2013
© 2013 thepharmaletter.com